公开(公告)号：US20220184074A1

公开(公告)日：2022-06-16

申请号：US17612778

申请日：2020-05-20

申请人： NOVARTIS AG

发明人： Souvik BHATTACHARYA ,  Bruno BIETH ,  Maciej CABANSKI ,  Bruno CENNI ,  Stefan DE BUCK ,  Martin KAUL ,  Arvind KINHIKAR ,  Andrijana RADIVOJEVIC ,  Thomas SEVERIN ,  Julian STORIM ,  Alessandra VITALITI GARAMI

IPC分类号： A61K31/505 ,  A61P17/00

摘要： The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using a compound of Formula (I) or a pharmaceutically acceptable salt thereof. Also disclosed herein is a compound of Formula (I) or a pharmaceutically acceptable salt thereof, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.